ÂÜÀòÂÒÂ×

John Magee is an experienced pharmaceutical executive with a comprehensive background in leadership roles across various companies. Currently serving as the VP, US Business Lead for Givosiran and Lumasiran at Alnylam Pharmaceuticals since March 2019, John is responsible for developing field structures and customer strategies for successful product launches. Previously, John held several key positions at Shire Pharmaceuticals, including Vice President and Head of Sales in the Rare Disease Business Unit and National Sales Director for the Renal Business Unit. Additional experience includes serving as VP of Sales at Flexion Therapeutics, East Region Executive Sales Director at Esprit Pharma, and East Zone Vice President and Head of Sales at Bayer Pharma. John Magee holds a degree from Hamilton College.